tiprankstipranks
Trending News
More News >
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
US Market

Sutro Biopharma (STRO) Income Statement

Compare
720 Followers

Sutro Biopharma Income Statement

Last quarter (Q3 2025), Sutro Biopharma's total revenue was $9.69M, an increase of 13.77% from the same quarter last year. In Q3, Sutro Biopharma's net income was $-56.86M. See Sutro Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 62.04M$ 153.73M$ 67.77M$ 61.88M$ 42.72M
Gross Profit
$ 54.83M$ 146.91M$ 59.48M$ 52.11M$ -34.24M
Operating Expenses
$ 293.28M$ 236.19M$ 188.43M$ 150.63M$ 36.82M
Depreciation and Amortization
$ 7.22M$ 6.82M$ 8.29M$ 4.84M$ 4.30M
EBITDA
$ -180.45M$ -67.92M$ -105.07M$ -97.56M$ -23.75M
Operating Income
$ -238.45M$ -89.28M$ -128.94M$ -98.52M$ -71.06M
Other Income/Expenses
$ 13.36M$ 677.00K$ 12.24M$ -7.01M$ 38.93M
Pretax Income
$ -225.10M$ -88.60M$ -116.70M$ -105.54M$ -32.13M
Net Income
$ -227.46M$ -106.79M$ -119.20M$ -105.54M$ -32.13M
Per Share Metrics
Basic EPS
$ -29.60$ -17.80$ -23.50$ -22.90$ -9.90
Diluted EPS
$ -29.60$ -17.80$ -23.50$ -22.90$ -9.90
Weighted Average Shares Outstanding
7.68M 6.02M 5.07M 4.61M 3.26M
Weighted Average Shares Outstanding (Diluted)
7.68M 6.02M 5.07M 4.61M 3.26M
Currency in USD

Sutro Biopharma Earnings and Revenue History